CME

Revolutionizing the Treatment of Neovascular Retinal Disease by Targeting the Angiopoietin-Tie Pathway

Revolutionizing the Treatment of Neovascular Retinal Disease by Targeting the Angiopoietin-Tie Pathway

This activity is supported by an educational grant from Genentech, Inc.

Overview

CME Information

page 1 of 8